Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Cash on Hand 2021–2025
Amylyx Pharmaceuticals, Inc. Common Stock annual cash on hand history from 2021 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand as of December 31, 2025: 226.7M, a 192.86% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2025 were 226.7M, a 192.86% increase from 2024.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2024 were 77.4M, a 54.53% decrease from 2023.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2023 were 170.2M, a 172.21% increase from 2022.
- Amylyx Pharmaceuticals, Inc. Common Stock cash on hand for 2022 were 62.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amylyx Pharmaceuticals, Inc. Common Stock Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $227 |
| 2024 | $77 |
| 2023 | $170 |
| 2022 | $63 |
| 2021 | $50 |
Amylyx Pharmaceuticals, Inc. Common Stock Cash on Hand — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's cash on hand history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's cash on hand by year and by quarter, including the growth rate.